Results 71 to 80 of about 351,379 (204)

Molecular Profiling of Prostate Cancer Patients [PDF]

, 2009
In the UK, more than 30 000 men are diagnosed annually with prostate cancer (PCa) and about 10 000 men die from it each year. Although several molecular markers have been associated with prostate cancer development and/ or progression, only few of them
Nna, Emmanuel Okechukwu
core  

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. [PDF]

, 2012
BACKGROUND: The natural history of prostate cancer is highly variable and it is difficult to predict. We showed previously that a cell cycle progression (CCP) score was a robust predictor of outcome in a conservatively managed cohort diagnosed by ...
Younus, A, Stone, S, M Perry, Mesher, D, A Gutin, J S Lanchbury, Scardino, P, H Møller, A Younus, Gutin, A., J Park, Stone, S., Cuzick, J, D M Berney, Lanchbury, JS, D Mesher, Scardino, P., Mesher, D., J Cuzick, Berney, D. M., Moller, H.; id_orcid, Cuzick, J., Reid, JE, Lanchbury, J. S., Berney, DM, Fisher, G., Perry, M, Transatlantic Prostate Group, P Scardino, S Stone, Foster, C. S., Fisher, G, Møller, H, Foster, CS, Reid, J. E., G Fisher, C S Foster, Younus, A., J E Reid, Park, J., Gutin, A, Park, J, Perry, M.   +42 more
core   +1 more source

Generation and application of recombinant antibody fragments for prostate cancer detection. [PDF]

, 2010
Prostate cancer (PCa) is the most prevalent adenocarcinoma and the second highest cause of cancer-related deaths in men. Early diagnosis is required to identify the development of PCa to reduce the risk of the disease metastasising to different regions ...
Hayes, Conor
core  

Correlation between Serum Prostate-Specific Antigen Level with Pathological Grade and Size of Prostate in Prostate Cancer Patients

SVU - International Journal of Medical Sciences
Background: The most prevalent type of cancer in males is prostate cancer, with bone being the most common location of metastases. Objectives: to examine the connotation among serum prostate-specific antigen levels and the pathological grade and size ...
Gamal A. Alsagheer , Mohamed Mostafa Ali Wahman , Ahmed El-Tamawy Abdelreheem Mohamed   +2 more
doaj   +1 more source

Molecular and functional analysis of the tumour antigen T21 [PDF]

, 2015
Immunotherapy is a valuable approach to target tumour cells by stimulating the body’s adaptive immune system. To achieve this objective, it is important to identify and study antigens that are distinctively expressed in cancer and can be used effectively
Alshehri, BM
core  

Engineered antibody and neuropeptide mediated radionuclide targeting in prostate cancer [PDF]

, 2010
PhDProstate cancer (PC) is the most common cancer type in men in the western world and to date no definitive stratergy to image PC is avaliable. This thesis explores the possibility of using Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing
Kashani, Roxana M G, Kashani, Roxana M. G.   +1 more
core  

Prostate-specific Membrane Antigen: Diagnostics. [PDF]

Since its clinical introduction in May 2011, prostate-specific membrane antigen (PSMA)-PET/computed tomography has quickly gained worldwide recognition as a significant breakthrough in prostate cancer diagnostics.
Seifert, Robert, Rowe, Steven P, Alberts, Ian L, Afshar-Oromieh, Ali, Werner, Rudolf A   +4 more
core   +1 more source

Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients [PDF]

, 2013
Prostate cancer is the second cause of cancer in males. The prophylactic pelvic irradiation is usually needed for treating prostate cancer patients with Subclinical Nodal Metestases.
B. De Bari, Stefano M. Magrini, M. Vallati, Jereczek-Fossa, Barbara,, Jereczek-Fossa, Barbara, Mauro Vallati, Gatta, Roberto, R. Gatta, F. Bertoni, MAGRINI, Stefano Maria, De Bari, Berardino, Filippo Bertoni, Bari, Berardino, De, Buglione, Michela, Bari, Berardino,, Magrini, Stefano, M., Magrini, Stefano M., Berardino De Bari, Magrini, Stefano, Roberto Gatta, Vallati, Mauro, Michela Buglione, BUGLIONE DI MONALE E BASTIA, Michela, Jereczek-Fossa, Barbara A., Jereczek-Fossa, Barbara, A., Magrini, Stefano,, Bertoni, Filippo, Barbara A. Jereczek-Fossa, B. A. Jereczek Fossa   +28 more
core   +1 more source

Incidental malignancies identified during staging for prostate cancer with 68 Ga prostate-specific membrane antigen HBED-CC positron emission tomography imaging [PDF]

, 2017
The rapid uptake of 68Ga prostate-specific membrane antigen HBED-CC positron emission tomography (PSMA PET) imaging for prostate cancer staging has led to concerns regarding its specificity, with uptake in both malignant and nonmalignant tissues.
Miles, K, Vela, I, Andre Joshi, Gustafson, S, Vela, Ian, Rhee, H, Nicholson, C, Handoo Rhee, Nicholson, Cheryl, Sonja Gustafson, Joshi, A, Rhee, Handoo, Cheryl Nicholson, Joshi, Andre, Miles, Kenneth, Kenneth Miles, Ian Vela, Gustafson, Sonja   +17 more
core   +1 more source

PROSTATE SPECIFIC ANTIGEN AFTER TRANSURETHRAL RESECTION OF PROSTATE

Urology Research and Practice, 2019
-
Doğan ERDEN, Temuçin ŞENKUL, Kenan KARADEMİR, Bilal Fırat ALP   +3 more
doaj   +2 more sources